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Background: Periodontal disease is the most common oral disease affecting adults, and although it is largely
preventable it remains the major cause of poor oral health worldwide. Accumulation of microbial dental plaque is
the primary aetiological factor for both periodontal disease and caries. Effective self-care (tooth brushing and
interdental aids) for plaque control and removal of risk factors such as calculus, which can only be removed by
periodontal instrumentation (PI), are considered necessary to prevent and treat periodontal disease thereby
maintaining periodontal health. Despite evidence of an association between sustained, good oral hygiene and a
low incidence of periodontal disease and caries in adults there is a lack of strong and reliable evidence to inform
clinicians of the relative effectiveness (if any) of different types of Oral Hygiene Advice (OHA). The evidence to
inform clinicians of the effectiveness and optimal frequency of PI is also mixed. There is therefore an urgent need
to assess the relative effectiveness of OHA and PI in a robust, sufficiently powered randomised controlled trial (RCT)
in primary dental care.
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Methods/Design: This is a 5 year multi-centre, randomised, open trial with blinded outcome evaluation based in
dental primary care in Scotland and the North East of England. Practitioners will recruit 1860 adult patients, with
periodontal health, gingivitis or moderate periodontitis (Basic Periodontal Examination Score 0–3). Dental practices
will be cluster randomised to provide routine OHA or Personalised OHA. To test the effects of PI each individual patient
participant will be randomised to one of three groups: no PI, 6 monthly PI (current practice), or 12 monthly PI.
Baseline measures and outcome data (during a three year follow-up) will be assessed through clinical examination,
patient questionnaires and NHS databases.
The primary outcome measures at 3 year follow up are gingival inflammation/bleeding on probing at the gingival
margin; oral hygiene self-efficacy and net benefits.
Discussion: IQuaD will provide evidence for the most clinically-effective and cost-effective approach to managing
periodontal disease in dentate adults in Primary Care. This will support general dental practitioners and patients in
treatment decision making.
Trial registration: Protocol ID: ISRCTN56465715
Keywords: Oral hygiene advice, Scale and polish, Prevention, Toothbrushing advice, Periodontal instrumentation, RCT,
Primary careBackground
Periodontal disease is the most common oral disease af-
fecting adults. This disease is largely preventable, yet it
remains the major cause of poor oral health worldwide
and is the primary cause of tooth loss in older adults [1].
Accumulation of microbial dental plaque is the primary
aetiological factor for both periodontal disease and caries.
Susceptibility to periodontal disease is also influenced by
the host’s defence mechanisms to bacterial infection and
other risk factors such as calculus and smoking [2]. Peri-
odontal disease affects tissues surrounding and supporting
the teeth and is classified into two broad categories: gingi-
vitis and periodontitis. Gingivitis is a reversible condition
characterised by inflammation and bleeding at the gingival
margin. It is a pre-requisite for periodontitis and is also a
risk indicator for caries progression [3]. Periodontitis is
the irreversible destruction and loss of the supporting
periodontal structures (periodontal ligament, cementum
and alveolar bone) [2]. The result is unsightly gingival re-
cession, sensitivity of the exposed root surface, root caries
(decay), mobility and drifting of teeth and, ultimately,
tooth loss.
Effective self-care (tooth brushing and interdental aids)
for plaque control and removal of risk factors such as
calculus, which can only be removed by periodontal in-
strumentation (PI), are considered necessary to prevent
and treat periodontal disease thereby maintaining peri-
odontal health.
The 1998 UK Adult Dental Health Survey (ADHS)
provides some evidence that the majority of UK adults
might be at risk of developing periodontal disease: 72%
of dentate adults had visible plaque, indicating tooth
brushing was ineffective, and 73% had calculus on at
least one tooth [4]. Forty-three percent of adults hadsome moderate periodontal disease (at least one periodon-
tal pocket with a probing depth of ≥ 4 mm< 6 mm) increas-
ing by age from 14% aged 16–24 to 85% ≥65. Indicators of
severe disease (periodontal pocket depth ≥ 6 mm) also in-
creased with age affecting 31% of ≥65 year olds [4]. A re-
cent study of adults aged 20 to 55 in Scotland provided
evidence that the 1998 ADHS figures underestimate the
current extent of periodontal disease. Only 15% exhibited
no clinical signs of disease and 63% exhibited moderate
disease [5].
Despite evidence of an association between sustained,
good oral hygiene and a low incidence of periodontal
disease and caries in adults [5] there is a lack of strong
and reliable evidence to inform clinicians of the relative
effectiveness (if any) of different types of Oral Hygiene
Advice [6] (OHA).
A number of relevant systematic reviews evaluating
OHA have been conducted with some inconsistency in
their findings [7-9]. The most recent, a Cochrane review
of psychological interventions to improve adherence to
oral hygiene instruction in adults with periodontal disease
found evidence that psychological interventions resulted
in improvements in oral hygiene related behaviours and
self-efficacy beliefs [7]. However, only four low quality tri-
als were eligible for inclusion and the authors concluded
there was a need for greater methodological rigour in
trials in this area. A review of studies reporting clinical
health outcomes concluded that most OHA interventions
provide a short-term (≤ 6 month) reduction in plaque and
gingival bleeding [6]. The authors highlighted the lack of
and need for studies to assess the sustainability of these
short-term benefits.
The evidence to inform clinicians of the effectiveness
and optimal frequency of PI is mixed. The West Midlands
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of PI (including root planing) for chronic periodontal dis-
ease in specialist settings concluded that the quality of the
research base, in terms of study design, quality of report-
ing and statistical reporting, was poor. Some positive ef-
fects (reduction in pocket depth and bleeding on probing)
were found, but the marginal effect of quarterly PI over
annual PI was small. No long term studies where annual
PI was carried out were identified; no studies investigated
patient centred outcomes; and the authors highlighted the
need for further research to determine the generalisabi-
lity of the findings to general dental practice [10]. The
Cochrane systematic review of PI (i.e. single-visit peri-
odontal instrumentation without root planing) for adults
found the evidence for effectiveness and optimal fre-
quency to be weak and unreliable, providing little guid-
ance for policy makers, dental professionals or patients
[11]. Only nine trials were eligible for inclusion, all had a
high risk of bias and it was not possible to carry out a
meta-analysis. Given that PI is routinely provided in gen-
eral dental practice it is noteworthy that none of the eli-
gible trials were conducted in primary care, included
patient centred outcomes, economic analyses or long term
effects. Evidence from a recent systematic review suggests
that stability of clinical attachment for patients with a his-
tory of chronic periodontitis receiving supportive peri-
odontal care (non-surgical and surgical) is greater, but less
cost-effective, in specialist settings than in general practice
settings. However, this conclusion was based on only three
studies and the estimates of cost-effectiveness used data
from only one study. The need for further research, in-
cluding research investigating patients’ willingness to pay,
was highlighted [12].
There is therefore an urgent need to assess the relative
effectiveness of OHA and PI in a robust, sufficiently
powered randomised controlled trial (RCT) in primary
dental care.
Trial aim
The aim of this study is to compare the effectiveness and
cost-effectiveness of theoretically based, personalised oralFigure 1 Study design.hygiene advice (OHA) or periodontal instrumentation (PI)
at different time intervals (no PI; 6 monthly PI or 12
monthly PI) or their combination, for improving periodontal
health in dentate adults attending general dental practice.
Objectives
The primary objectives are to test the effectiveness and
cost effectiveness of the following dental management
strategies:
a) Personalised OHA versus routine OHA;
b) 12 monthly PI versus 6 monthly PI;
c) No PI versus 6 monthly PI.
The secondary objectives include:
d) To test the effectiveness and cost-effectiveness of a
combination of personalised OHA with different
time intervals for PI;
e) To measure dentist/hygienist beliefs relating to
giving OHA, PI and maintenance of periodontal
health.
Methods/Design
This is a 5 year multi-centre, randomised, open trial with
blinded outcome evaluation. The comparisons will be
made within a factorial design using a combination of
cluster and individual participant randomisation. As per-
sonalised OHA will be given by the dentist or hygienist,
there is a theoretical risk of “contamination” between
patient participants seen within the same dental practice
(i.e. the dentist will give personalised OHA to participants
allocated to routine care). To minimise this potential risk,
dentists will be randomised to either a routine or a perso-
nalised OHA group. All patient participants seen by the
same dentist or hygienist (a “cluster”) will receive either
routine (current practice) or personalised OHA depending
on their dentist’s allocation. To test the effects of PI each
individual patient participant will be randomised to one of
three groups: no PI, 6 monthly PI (current practice), or 12
monthly PI Figure 1.
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In general dental practice both OHA and PI can be de-
livered by a dentist or by a dental hygienist. The trial will
recruit dentists however the interventions will be deliv-
ered by the dentist or by the hygienist in line with each
individual dentist’s usual practice.
Routine OHA
Routine OHA indicates current practice. There is no pub-
lished information describing “routine” OHA, but anec-
dotal evidence suggests that this is often the provision of
minimal advice (e.g. “you need to brush your teeth more
frequently” or no advice).
Personalised OHA
The content and delivery of the intervention is sum-
marised as a series of steps in Figure 2. We will use a
personalised OHA intervention based upon Social Cog-
nitive Theory [13] and Implementation Intention Theory
[14]. The content of the advice delivered will be perso-
nalised according to the dentist’s/hygienist’s assessment
of the needs of the patient. At a minimum the content
will include advice and instruction in self diagnosis (e.g.
bleeding gums on brushing indicates the presence of
reversible gingival inflammation) and advice and instruc-
tion on tooth brushing and flossing (frequency and tech-
nique). Upon completion of the advice, the dentist will
agree an action plan with the patient. The feasibility and
utility of including personalised biofeedback [15] in the
personalised OHA intervention will be considered by
the research team and the Periodontal Advisory Group.
Dentist allocation to OHA group
Recruited dentists will be allocated to routine or persona-
lised OHA by minimisation on two factors - (i) practice
employs dental hygienist (yes/no) and (ii) practice size
(2 or less dentists in practice/3 or more dentists). This
cluster level randomisation will be conducted after the
dental consent form is received at the Trial CoordinatingThis is what you need to do
• Brush twice a day
• Brush for 2 minutes
• Use fluoride toothpaste
• Spit don’t rinse
• Clean teeth feel smooth to 
the tongue
This is how you do it
Dentist shows tooth brushing  
technique on mouth of model
Social Cognitive Theory
(Bandura, 1998)
Tell Show
Figure 2 The OHA intervention behavioural framework.Office in Dundee (TCOD) and before any patient has been
approached.
Training in delivery of the personalised OHA
Training in the delivery of the personalised OHA inter-
vention will be provided to all dentists/hygienists allo-
cated to this OHA group. Training will provided at half
day training sessions and, in addition, interactive DVDs
which include training and self-assessment elements will
be provided. Dentists/hygienists will retain these training
resources in order to be able to undertake self-directed
training as required throughout the trial.
Frequency of OHA
At baseline all patients will receive OHA according to
cluster level randomisation. Reinforcement of OHA will
be provided at the discretion of the dentist/hygienist
during the trial and recorded.
Periodontal Instrumentation (PI)
The definition of periodontal instrumentation is as used
in standard practice and may include the removal of
plaque and calculus from the crown and root surfaces
using manual or ultrasonic scalers, with no adjunctive
sub-gingival therapy e.g. antibiotics [17], and the appro-
priate management of plaque retention factors.
Baseline PI
A full mouth supra and sub-gingival PI will be carried
out by the dentist/hygienist on all participants prior to
randomisation. No time limit will be set on this treat-
ment and dentists/hygienists will be instructed to scale
the teeth and root surfaces until they are free of all de-
posits and are smooth to probing.
Experimental PI
Experimental groups will receive a PI at six or 12
monthly intervals according to the individual patient-Now, please clean your teeth 
using this toothbrush, so that 
I can check your technique
Dentist
• Corrects if required
• Ask how teeth feel
• Ask if now confident
• Praises
Before you go, can you tell me 
when will be the best time 
for you to brush your teeth?
Dentists elicits an action plan
Implementation Intention Theory 
(Gollwitzer, 1999)
nalPoD
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groups will attend their dentist at time intervals which
are determined by current practice. However, if a patient
allocated to the no PI group does not attend their den-
tist for an appointment within 12 months the dentist will
be asked to call them in for an appointment.
Patient participant allocation to PI group
Patient participants’ allocation to the PI trial arms will
use the automated, central randomisation service at the
Centre for Healthcare Randomised Trials (CHaRT), Uni-
versity of Aberdeen, with access both by telephone and
web. Allocation will take place once the outcome asses-
sor has completed the baseline outcome assessment and
will be minimised on (i) absence of gingival bleeding on
probing (yes/no), (ii) highest sextant BPE score (BPE less
than 3/BPE 3) and (iii) current smoking (yes/no). The
outcome assessors will be informed that allocation has
taken place. However, the actual allocation will be trans-
mitted to the TCOD (thereby keeping the outcome as-
sessors blinded to allocation). A letter will be sent to
patient participants to inform them of their trial group
allocation and the practice will be contacted by the
TCOD to arrange the first intervention appointment.
The patient participant’s trial group allocation and date
of first PI intervention appointment will be entered into
an automated reminder system. For participants allo-
cated to the “no PI” groups no PI intervention appoint-
ments will be made and these participants will attend
their dentist as per current practice. However, the TCOD
will arrange a routine check-up appointment for patients
allocated to these groups who do not attend their dentist
at least once in every 12 month period.
Study recruitment and allocation
Study recruitment - identifying and recruiting dentists
We propose to utilise existing collaborative links with
Practitioner Services Division Scotland (PSD), and the
NHS Business Services Authority England/Wales (NHSBSA).
Each of these agencies maintains a database detailing all
courses of NHS treatment provided. Agreement will be
sought to use these databases, with the appropriate data
protection safeguards in place, to identify all potentially
eligible dentists. The information identifying dentists is
publicly available from each Health Board/Primary Care
Trust. The databases we propose to use collate this in-
formation making identification more efficient.
The Trial Co-ordinating Office in Dundee (TCOD)
will send potential dentist participants an invitation let-
ter, describing the study and the dentist will be phoned
to confirm their attendance to the recruitment session.
Dentists who indicate they would like to be contactedabout the trial will be invited to a local information and
recruitment session.
Identifying and recruiting patients
The identification of potential patients in each dental
practice will be supported by staff from the Scottish Pri-
mary Care Research Network in Scotland and the UK
Clinical Research Network in England. Dentists will
identify the patients” addresses and will then send the
patient invitation letter, information sheet and baseline
patient questionnaire to each potential participant with
an appointment to attend a screening session in the den-
tal practice. This will be sent at most six weeks in ad-
vance. At this stage patients who are not interested in
taking part will be asked to phone the practice to be sent
an alternative appointment to see their dentist. At the
screening appointment the dentist will discuss the trial
with the potential participants and answer any questions.
The outcome assessor, who will be a qualified hygienist
employed on the trial, will be present at this appoint-
ment. Those who state they do not wish to take part will
then be seen by their dentist/hygienist who will provide
OHA and/or PI as normal. Eligibility of those who ex-
press an interest in taking part will be checked by the
outcome assessor and confirmed against pre-defined cri-
teria. Those who are eligible will be consented to the
trial by the outcome assessor. Baseline questionnaires
will then be collected and baseline clinical outcomes will
be measured by the outcome assessor before the dentist/
hygienist provides the baseline PI. For those patients
excluded from the trial solely on BPE score 4 or *, con-
sent will be sought to follow them up with the annual
questionnaire.
Inclusion criteria
Adult patients (≥ 18 years of age) with periodontal
health, gingivitis or moderate periodontitis (Basic Peri-
odontal Examination (BPE) score 0–3) who:
 Are dentate.
 Have attended for a check-up at least twice in the
previous 2 years.
 Receive their dental care in part or fully as an NHS
patient.
Exclusion criteria
 Patients with periodontal disease with a BPE score
of 4 (probing depth > 6 mm and/or furcation
involvements or attachment loss of 7 mm or more)
in any sextant on the basis more extensive
periodontal care is indicated.
 Patients with an uncontrolled chronic medical
condition (e.g. diabetes, immunocompromised).
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Primary outcomes
Clinical: gingival inflammation/bleeding on probing at
the gingival margin at 3 year follow-up;
Patient Centred: oral hygiene self-efficacy at 3 year
follow-up;
Economic: Net benefits (mean willingness to pay minus
mean costs).
Secondary outcomes
Clinical: 1) calculus, 2) periodontal pocket depth, 3) add-
itional PI, 4) referral (all at 3 year follow-up)
Patient Centred: 1), dental quality of life, 2) oral health
behaviour, 3) knowledge; (annual follow-up to 3 years)
Economic: Costs to the NHS and patients; willingness
to pay
Providers: Beliefs relating to giving oral hygiene advice
and maintenance of periodontal health.
Note: The Periodontal Advisory Group considers that
clinical attachment loss (CAL) and plaque cannot be mea-
sured reliably and so neither are included as outcomes.
Data collection and processing
Participating dental practices will be expected to main-
tain a file of essential trial documentation which will be
provided by the TCOD.
Collection of clinical outcome measures
Clinical outcomes will be measured at baseline and at
three years follow-up by trained outcome assessors who
are blinded to allocation. Gingival inflammation as bleed-
ing will be measured according to the Gingival Index of
Löe [16] by running a University of North Carolina
(UNC) probe circumferentially around each tooth just
within the gingival sulcus or pocket. After 30 seconds,
bleeding will be recorded as being present or absent on
the buccal and lingual surfaces. The colour-coded UNC
periodontal probe will be used to measure periodontal
pocket depth and presence of calculus. Clinical out-
comes will be measured for all teeth (excluding third
molars) at 6 sites per tooth [mesiobuccal, midbuccal,
distobuccal, mesiolingual/palatal, mid-lingual/palatal
and distolingual/palatal]. The sequence of scoring will
be gingival inflammation/bleeding, periodontal pocket
depths and calculus.
Additional PI and referral will be measured annually
by self-administered patient questionnaire and at three
years from routinely collected data.
Collection of patient centred outcome measures
Patient centred outcomes will be measured at baseline
and annually by self-administered postal questionnaire.
Quality of life will be measured using the Oral Health
Impact Profile-14 (OHIP-14) [17]. Issues of cosmesis willbe explored. The questions for measuring patient and
provider beliefs are derived from Social Cognitive The-
ory [13] and the Theory of Planned Behaviour [18].
For patient participants who fail to attend their year
three assessment appointments all efforts will be made
to collect clinical outcome data and questionnaires will
be posted.
Collection of economic measures
Time, travel and treatment costs associated with all visits
to the dentists/hygienists will be collected by question-
naires administered to patients at the baseline visit.
Questionnaires recording the costs of any treatment
provided will be completed by the dentist/hygienist.
Contact with other health services will be assessed via
the annual patient questionnaire.
Benefits to patients of the various interventions will be
measured over a number of dimensions. The effective-
ness of the intervention will be measured by the out-
comes listed above. Public preferences will be elicited
regarding the relative importance of these outcomes
from a discrete choice experiment (DCE) (see economic
analysis. The DCE will be administered to a separate
sample of the public obtained from an online marketing
company over the course of the trial.
Scheduling of events
Data will be collected as detailed in Table 1.
Analysis plan
Statistical analyses
The factorial design of the trial allows for the main ef-
fects and interactions between interventions to be exam-
ined. Reflecting the clustering in the data, the outcomes
will be compared using multilevel models, with adjust-
ment for minimisation variables [19]. Statistical signi-
ficance will be at the 2.5% level and corresponding
confidence intervals will be derived. All participants will
remain in their allocated group for analysis (intention to
treat). Subgroup analyses using interaction terms will ex-
plore the possible effect modification of a number of fac-
tors (See Sub group analysis), all using stricter levels of
statistical significance (p < 0.01). Missing patient re-
ported outcomes will not be imputed at the follow-up
time points for the primary analyses. However, we will
investigate the mechanism of missingness using regres-
sion models [20] and apply an appropriate missing data
model as a sensitivity analysis [21]. All trial analyses will
be according to a statistical analysis plan that will be
agreed in advance by the Trial Steering Committee
(TSC). The Data Monitoring and Ethics Committee
(DMEC) will meet at 9, 24 and 36 months to review pro-
gress and recommend any divergences from planned
trial design.
Table 1 Scheduling of events
Screening Baseline 12 months 24 months 36 months
Assessment for eligibility X
Informed consent X
Gingival bleeding X X
BPE score X X
Calculus X X
Pocket depth X X
QoL questionnaire (OHIP-14) X X X X
Knowledge, attitudes, beliefs questionnaire X X X X
Costs questionnaire X X
Clinician belief questionnaire X X
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the trial when all follow-up has been completed. Un-
blinded interim analyses will be conducted for the DMEC
meetings as required.
Sub group analysis
 Patient participant age (years):- < 45, 45 to 64, ≥ 65;
 Smoking:- non-smoker or smoker;
 Periodontal disease severity:- no clinical signs,
presence of gingival bleeding on probing, pocket
depth ≤ 4 mm or > 4 mm;
 Intervention provider:- dentist or practice hygienist.
Economic analyses
Estimation of costs
Health care resource utilisation data will be combined
with unit cost information for the use of specific re-
sources provided by the participating practices; use of
routine data sources and patient participants’ time, travel
and out-of- pocket costs (for the latter this will only in-
clude costs not otherwise collected from participating
practices). Data on costs for each area of service use will
summed to provide an average cost per patient partici-
pant. Sensitivity analysis will be used to explore the im-
pact of price paid by patient participants on the uptake
of dental services. These data will be used to consider
whether use of services systematically varies by the ex-
tent of NHS coverage.
Estimation of benefits
The benefit side of the economic evaluations will firstly
be based upon the effectiveness data detailed in outcome
measures. Patient’s may place different weight on these
different outcomes and also have preferences for the way
in which services are organised. A DCE will be used to
provide a framework to weight different process and
outcomes measures. DCEs are increasingly used in the
evaluation of health care interventions to produceoverall benefit scores for treatments as well as examine
the absolute and relative importance of different out-
comes considered as important. This approach has been
adopted as measures such as quality adjusted life years
typically used in economic evaluations may not be suffi-
cient to capture the strength of preferences for differ-
ences in the process and outcomes of care associated
with each intervention. Briefly, DCEs describe an inter-
vention in terms of a number of characteristics or out-
comes (attributes). The extent to which an individual
values an intervention depends upon the levels of these
characteristics [22,23]. The technique involves present-
ing choices to individuals that imply a trade-off in terms
of the levels of the attributes. Experimental design tech-
niques are used to define the set of choices presented to
respondents and logit regression techniques are used to
analyse the response data.
The DCE will be administered to a separate sample of
the public obtained from an online marketing company.
Respondents will be part of a large online panel who will
be invited to complete on online survey via email. Panel-
lists are rewarded for the time they take to complete the
survey through a structured incentive scheme. They re-
ceive a cash reward for participating in individual sur-
veys – the amount is clearly stated in the invitation
email and related to the survey length, interest and com-
plexity (range between 50p-£5). Each panellist will be
assigned an individual ID, allowing the company to mo-
nitor panellist activity and distinguish between contact
rate (e.g. those who were initially contacted and did/did
not complete the survey) and completion rate (e.g. those
who completed the survey and did not drop out). This is
an approach that we have successfully used in previous
studies and overcomes the problems caused by very poor
response rates from samples drawn from the general
population.
The sample size required reflects the need for the sam-
ple to be larger than the number of independent variables
[24]; provide an adequate sample for each predetermined
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non-smoker or current smoker, social economic group
(high, medium and low), country (England, Scotland) (19
subgroups in total and 30–100 per subgroup [25]. Allow-
ing for individuals to be present in a number of groups,
the questionnaire will be administered online and a max-
imum of 950 individuals (19 × 50) completed questionnaires
will be sought.
In addition to the outcomes included in the DCE one
further attribute included will be patient cost. By including
this attribute, the willingness to pay (WTP) for a change
in the level of any other attribute will be estimated. This
information will be combined with the clinical outcomes
provided obtained from the trial for each participant and
about type of care provided to provide an estimate of the
mean WTP for each intervention considered.
Costs and benefits to the practitioner participant
Different frequencies of PI visits will impact upon clini-
cians’ costs and benefits. The effect on incomes, job satis-
faction and changes to the level of fees on the provision of
PI will be assessed using self-reported questionnaires ad-
ministered to clinicians over the duration of the trial.
Presentation of results
Results will be presented both as a cost-consequence
analysis (presentation of costs and outcomes, including
those to practitioners) and as incremental net benefits.
Net benefits will be calculated by combining estimates
of mean WTP with estimates of mean cost for each inter-
vention. The intervention with the greatest net benefit
would be considered the most efficient. The evaluation
will include both deterministic and probabilistic sensi-
tivity analysis, using methods developed for previous
analyses [26].
Sample size
An OHA exploratory trial in the same population as the
proposed trial demonstrated that at baseline 35% of gin-
gival sites were bleeding on probing with sd = 25% [27].
The PI Cochrane review suggested that a reduction of
15% of sites with bleeding was a plausible reduction for
6 monthly PI [12]. If the effect is assumed linear, halving
the number of PIs should half the expected difference of
15% of sites. If the effect is non linear and larger than
7.5%, the trial will be adequately powered. If the effect is
smaller it would be of questionable clinical significance.
There is some evidence that personalised OHA can re-
duce the number of gingival sites bleeding on probing
by approximately 7.5% [27]. The following calculations
are based on estimating main effects from the trial. All
calculations assume a significance level of 2.5% to give
some protection against multiple testing.OHA
To calculate the sample size required to estimate the main
effect of OHA, it is recognised that the data are contained
within a cluster RCT. Assuming a conservative estimate of
the intracluster correlation (ICC) of 0.0531, a cluster RCT
of 50 dentists collecting information from 25 patient par-
ticipants each (25*25 = 625 patients per arm) will have
90% power to detect a difference of 7.5%. Should the cor-
relation be 0.1, the trial will still have approximately 80%
power to detect a difference of 7.5%.
PI
Given that the comparison of routine versus persona-
lised OHA requires 625 patient participants in each arm,
equal randomisation 1:1:1 (no PI; 6 monthly; 12 monthly)
of patient participants implies 208 in each of the six
groups. Assuming no interaction effect, the corresponding
PI groups can be combined across both routine and perso-
nalised advice groups giving 416 patients allocated to each
PI group. Assuming a sample size of 416 in each group,
the trial will have in excess of 95% power for each pairwise
comparison to detect a difference of 7.5% in the percent-
age of gingival sites that bleed on probing.
Interaction
We do not anticipate a substantive interaction effect be-
tween the PI interventions and the personalised OHA. As-
suming an ICC of 0.05, the trial has 80% power to detect
an interaction effect of 7.5%. Should the ICC be 0.1, the
trial has approximately 80% power to detect an interaction
of 10%.
At trial endpoint the total number of dentists required
is 50 and the total number of participants is 1248 (6*208).
Our previous trials in general dental practice suggests that
we may lose a small number of dental practices in the trial
for reasons such as practices amalgamating with other
practices or restricting NHS patients. We have therefore
very conservatively assumed 17% attrition for dentists and
20% for participants. These assumptions imply that 60
dentists and 1860 participants will be required. Each den-
tist will be required to recruit on average 31 participants
to ensure 25 at follow-up.
Recruitment plans
The trial will recruit 60 dental practitioners from 60 gen-
eral dental practices in Scotland and North East England
(Newcastle). Participating dentists will represent a cross-
section of practitioners operating in a range of different
circumstances (e.g. urban or rural, high, middle or low in-
come communities, employing or not employing a dental
hygienist). The target recruitment is for 40 dental practi-
tioners to be in Scotland with the remainder in Newcastle.
Recruitment of 60 general dental practices is projected
to take 12 months and the 1860 participants recruited
Clarkson et al. BMC Oral Health 2013, 13:58 Page 9 of 12
http://www.biomedcentral.com/1472-6831/13/58within 16 months. The recruitment projection is shown
in Figure 3.
Ethical considerations
The project will be coordinated by a Trial Co-ordinating
Office (TCOD) in the Dental Health Services Research
Unit in the University of Dundee and CHaRT in the
University of Aberdeen. Both institutions are committed
to the highest standards of research governance and seek
to conform to all relevant governance guidelines and
codes of practice as detailed in the Research Governance
Framework and ICH guidelines for Good Clinical Practice
(GCP). As well as ensuring that research is conducted ac-
cording to the requirements set out in these documents,
all research will be conducted with the written agreement
of the relevant Multi-Centre and/or Local Research Ethics
Committee(s), and/or other relevant ethics committee(s)
before starting recruitment. Favourable ethical opinion for
the IQuaD study was confirmed by the East of Scotland
Research Ethics Service on 24th March 2011 (REC refer-
ence number 10/S0501/65).
A study information leaflet will be given to each poten-
tial participant to inform them of the anticipated risks and
benefits of taking part in the study. In particular, the
trade-offs between possible short-term benefits and long-
term risks will be explained.
Informed signed consent forms will be obtained from
the participants in all centres, by an individual who is
trained in GCP. Patients will be given sufficient time toFigure 3 Recruitment projections.accept or decline involvement and are free to withdraw
from the study at any time.
Data protection and archiving
Patients will be reassured that all data which are col-
lected during the course of the research will be kept
strictly confidential. All patients’ details will be anon-
ymised and stored on a database under the guidelines of
the 1998 Data Protection Act. The relevant research
documentation will be archived at the University of
Dundee for at least five years after completion of the
trial as required by the applicable regulatory require-
ment(s).
Governance arrangements
Research Governance applies to everyone working in the
Dental Health Services & Research Unit and CHaRT. As
such, all research will be conducted within the appropri-
ate legislative and regulatory environment and in ac-
cordance with GCP. All staff involved in the trial at the
two centres will have undertaken appropriate GCP train-
ing (to a level of knowledge that reflects their exposure
to the principles). The three main groupings that con-
tribute to the governance arrangements for this study
are: the Trial Management Committee; an independent
Trial Steering Committee (TSC); and an independent
Data Monitoring Committee (DMC). The Trial Steering
Committee (TSC) includes an independent Chairperson
(Elizabeth Treasure, Professor in Dental Public Health,
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clude Eleanor Grey, Consumer Representative, Tina
Halford-McGuff, and James McCaul and will oversee the
trial. The TSC also comprises a selection of the co-
applicants including the Principal Investigators (Clarkson
and Ramsay), the trial statistician and the Director of
CHaRT. There will only be two voting members drawn
from any of the co-applicants. The TSC will meet annually
throughout the course of the study.
The Data Monitoring and Ethics Committee (DMEC)
will be chaired by Damian Walmsley, (Professor of Re-
storative Dentistry, University of Birmingham) and in-
clude Peter Robinson and Pollyanna Hardy. It will meet
early in the trial to agree it’s terms of reference and
other procedures and will likely have further meetings at
9, 24 and 36 months. The DMEC will report any recom-
mendations to the Chair of the Steering Committee.
The University of Dundee has agreed to act as spon-
sor. As such, the TCOD will undertake to communicate
promptly and effectively with the sponsor to satisfy and
reassure the sponsor that the sponsor’s obligations on
the authorisations, the financing and the progress
reporting (including emerging safety data) of the trial
are being met. This may include providing comprehen-
sive information before the start of a trial for the pur-
poses of risk assessment for the sponsor.
Arrangements for day-to-day management of the trial
The trial will be co-ordinated from the TCOD in the
Dental Health Services Research Unit, Dundee, and will
provide day to day support for the clinical centres and
outcome assessors/research nurses. The TCOD will be
responsible for transacting the randomisation, collec-
ting all trial data (including postal questionnaires), co-
ordination of patient participant appointments, follow-up
and data processing. CHaRT, Health Services Research
Unit, Aberdeen University will provide the database appli-
cations and IT programming for the TCOD, and host the
randomisation system, co-ordinate the patient follow-up
questionnaires, provide experienced trial management
guidance, and take responsibility for all statistical aspects
of the trial (including interim reports to the TSC and
DMEC). The outcome assessors will be responsible for
recruiting participants (including initiating the randomisa-
tion call) and performing all clinical outcome assessments.
An Operations Management Committee, led by the Trials
Manager, will meet weekly in the early stages at the TCOD
to ensure smooth running of the trial, trouble-shooting is-
sues as they arise, and ensuring consistency of action
across the participating centres. CHaRT staff in Aberdeen
will join this group as required, weekly by teleconference,
and in person every 4–6 weeks. These face to face meet-
ings will become less frequent as the trial progresses suc-
cessfully, and increase again in frequency as the trialenters its closedown phase. A Trial Management Commit-
tee will meet biannually and be chaired by the Principal
Investigators, and include co-investigators and key mem-
bers of the TCOD and CHaRT. Their remit will be to
oversee the progress of the trial, and they will report to
the independent TSC.
Trial oversight
As described above, the trial will be overseen by a Trial
Steering Committee and a Data Monitoring and Ethics
Committee. In addition an expert Periodontal Advisory
Committee has been convened to provide expert clinical
advice to the Trial Management Committee throughout
the duration of the study.
Data monitoring
A Data Monitoring and Ethics Committee (DMEC) met
early in the trial and agreed it’s terms of reference and
other procedures. The DMEC will make any recommen-
dations to the chair of the Steering Committee.
Safety concerns
The design of the study ensures that adults for whom al-
location to a no-PI intervention may be detrimental are
not eligible to be included the study. Periodontal disease
and caries progress very slowly. During the trial partici-
pants will be monitored as per routine practice, possibly
more frequently than might otherwise have been the
case, and they may receive more frequent preventive oral
hygiene advice. It is made clear to both the patients and
their dentists that, within the design of the study, it is
acknowledged that patients may attend anytime a dental
appointment is needed and that these visits may be in
addition to any study-specified recall visits. Thus no
dental treatment, whether delivered in the dental surgery
or following referral to specialist services will be with-
held from patients as a result of taking part in this study.
The PI intervention being evaluated has been routine
in the NHS for many years and has no known safety
concerns.
Sponsorship
The University of Dundee is the sponsor of the research.
Finance
The study is supported by a grant from the National In-
stitute Health Research (NIHR) Health Technology As-
sessment Programme (ref 09/01/45).
Publication
The results of the study will be reported first to study
collaborators. A main report will be drafted by the pro-
ject management group and circulated to all clinical co-
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ered for publication by the steering committee.
Dissemination
The results of this trial will be disseminated widely and
actively through professional, primary care, public and
scientific routes. Results will be communicated directly
to all participating dental practices and an open work-
shop will be held with them discussing the next steps in
getting the findings of the study to influence clinical
practice. The trial results will be used to update Cochrane
reviews, inform policy (through targeted feedback to all of
the UK Health Departments and the British Association
for the Study of Community Dentistry and its Consultants
in Dental Public Health Group); practice (through specific
communications to the National Institute for Health and
Clinical Excellence (NICE), the British Dental Association
and the Faculty of General Dental Practice (UK)); the pub-
lic (through INVOLVE and patient organisations) as well
as with dental education and training (through a range of
communications to postgraduate dental Deans, the un-
dergraduate dental schools and if appropriate to aid the
development of educational support material developed
from the training CD-ROMs.
Given the current dearth of directly applicable evidence
around this important research question, it is anticipated
that the impact of this trial will also be felt at the Inter-
national level as well as closer to home (specific presenta-
tions will be made to the International Association for
Dental Research and its Evidence Based Dentistry Net-
work as well as to organisations such as the European As-
sociation for Dental Public Health and related European
specialty societies for research and practice.
Milestones for the IQuaD trial
Dental practice recruitment began in month 7. Patient
recruitment began in month 11 and is planned to con-
tinue until month 27. Follow up assessments will be
made at three years, so the last patient will be seen in
month 63.
Discussion
The IQuaD Trial is an NIHR HTA funded trial being
undertaken across the UK and will begin to address the
lack of high quality evidence to aide dental practitioners,
patients and policy makers in their decision making. As
a pragmatic, multi-centre, randomised, open trial with
blinded outcome evaluation, IQuaD aims to eradicate
the uncertainty that exists among dental practitioners
when treating and managing periodontal disease, by test-
ing the interventions in the environment that they will
most often delivered in, dental primary care.
In order to ensure the results of this trial are widely
applicable, the geographical areas that are included inthe IQuaD Trial have been selected to yield a cross-
section of practices, operating in a range of different en-
vironments and circumstances (e.g. high, middle or low
income communities, rural and urban, method of remu-
neration of GDPs (capitation and fee for item of service
or a banded payment system based on Units of Dental
Activity (UDA)).
The study team is multidisciplinary and broad-based,
and will be led the teams at the Dental Health Services
Research Unit, Dundee and the Centre for Healthcare
Randomised Trials in Aberdeen. This will ensure that
whilst the trial design and conduct is of the highest
standard, it remains practical and pragmatic at all times.
We expect the IQuaD Trial to provide evidence that will
benefit the future dental care, improve outcomes of
treatment and inform decision making by policy makers,
clinicians and patients, within and out with the UK Na-
tional Health Service.
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